-
EVALUATION OF EVIDENCE SOURCE AND ANALYSES TYPE PRESENTED IN RARE DISEASE NICE SUBMISSIONS AS INCLUSION IN JCA APPROACHES
Aug 11, 2026, 17:16 PM -
GREECE'S STRUCTURAL CO-PAYMENT BURDEN OF PATIENTS WITH MULTIMORBIDITY—A 13-COUNTRY EUROPEAN COMPARISON
Aug 11, 2026, 17:16 PM -
WHEN EVIDENCE IS NON-RANDOMIZED: HTA DECISIONS IN ATMPS ASSESSMENTS. A CROSS-AGENCY TARGETED REVIEW
Aug 11, 2026, 17:16 PM -
A SOCIAL MEDIA LISTENING ANALYSIS OF PERCEIVED HEALTH IMPROVEMENTS ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) USE BEYOND WEIGHT-LOSS AND DIABETES-FOCUSED COMMUNITIES
Aug 11, 2026, 17:16 PM -
MOST FAVOURED NATION DRUG PRICING IN THE US: WHY A NATIONAL HTA AGENCY IS NEEDED BEYOND INTERNATIONAL REFERENCE PRICING
Aug 11, 2026, 17:16 PM -
DISEASE BURDEN AND HEALTHCARE UTILIZATION AFTER DIAGNOSIS OF NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS (NF1-PN) IN SWEDISH ADULT PATIENTS: A REGISTRY-BASED STUDY
Aug 11, 2026, 17:16 PM -
PAYER PERSPECTIVES ON THE POTENTIAL IMPACT OF US MOST-FAVOURED-NATION POLICIES ON PHARMACEUTICAL PRICING AND ACCESS: FINDINGS FROM A MULTI-COUNTRY QUALITATIVE ASSESSMENT
Aug 11, 2026, 17:16 PM -
REGIONAL VARIATION IN PRESCRIPTION DRUG USE IN PUBLIC REIMBURSEMENT CLAIMS IN JAPAN: AN ANALYSIS OF NDB OPEN DATA
Aug 11, 2026, 17:16 PM -
FIFTEEN YEARS OF GERMAN HTA (AMNOG): TRENDS AND DRIVERS OF "NO ADDED BENEFIT"
Aug 11, 2026, 17:16 PM -
HPV TESTING VERSUS VISUAL INSPECTION WITH ACETIC ACID FOR CERVICAL CANCER SCREENING IN MOROCCO . A COST-UTILITY ANALYSIS BASED ON A MARKOV MODEL
Aug 11, 2026, 17:16 PM -
ACCEPTANCE OF ARTIFICIAL INTELLIGENCE IN MEDICAL CONSULTATIONS: EVIDENCE FROM A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
TACKLING SOCIOECONOMIC INEQUALITIES ASSOCIATED WITH MENINGITIS AND ENCEPHALITIS AND THE ROLE OF RAPID MULTIPLEX TESTING
Aug 11, 2026, 17:16 PM -
ASSESSING THE INCREMENTAL VALUE OF PATIENT EXPERIENCE EVIDENCE IN HTA AND REIMBURSEMENT DECISION-MAKING
Aug 11, 2026, 17:16 PM -
GLOBAL BURDEN AND TEMPORAL TRENDS OF HIP OSTEOARTHRITIS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY
Aug 11, 2026, 17:16 PM -
CLOSING THE LANGUAGE GAP IN HEOR REVIEWS: VALIDATING AI-ASSISTED SCREENING OF CHINESE-LANGUAGE EVIDENCE
Aug 11, 2026, 17:16 PM -
TREATMENT PREFERENCES FOR PHARMACOLOGICAL THERAPIES IN ALZHEIMER'S DISEASE: A SCOPING REVIEW OF STATED-PREFERENCE STUDIES
Aug 11, 2026, 17:16 PM -
INDIRECT COMPARISONS FOR HEALTH TECHNOLOGY ASSESSMENT: A PRACTICAL METHODOLOGICAL GUIDE AND TIPS WITH INSIGHTS FROM THE FRENCH TRANSPARENCY COMMISSION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ETRANACOGENE DEZAPARVOVEC VERSUS FACTOR IX PROPHYLAXIS FOR SEVERE OR MODERATELY SEVERE HAEMOPHILIA B IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
BENCHMARKING DAY SURGERY POTENTIAL IN HUNGARY USING THE BEDS METHODOLOGY: THEORETICAL RESERVES IN CASE VOLUMES AND HOSPITALIZATION DAYS, 2015-2025
Aug 11, 2026, 17:16 PM -
IDENTIFICATION OF TREATMENT EFFECT MODIFIERS (TEMS) AND PROGNOSTIC FACTORS (PFS) IN MATCHING-ADJUSTED INDIRECT COMPARISONS (MAICS)- A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM
